UK start-up Genomics has raised £35mn as it seeks to accelerate the adoption of polygenic risk scores to help people predict and prevent diseases through partnerships with healthcare systems and pharma companies.
英国初创企业Genomics已经筹集了3500万英镑，它希望通过与医疗保健系统和制药公司合作，加快采用多基因风险评分来帮助人们预测和预防疾病。
您已阅读11%（440字），剩余89%（3673字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。